S. Jordan Associates (SJA)
SJA Investment Banking: Fundraising required to support the advancement of scientific development programs is one of the most prominent challenges facing life sciences / medical device company executives. SJA assists emerging growth companies raise financing rounds, achieve "exits" / liquidity via M&A, APOs (reverse mergers, direct listings), facilitate investor outreach, negotiate licensing terms with strategic partners, and close transactions facilitating increases in shareholder value. SJA’s network of investors includes retail (Accredited / Angel / Family Office) and institutional (venture capital) investors supporting private and public raises including concurrent financings associate with private-to- public transactions. SJA Consulting: Provide strategic advisory services to healthcare companies including business development - identify, structure, and negotiate licensing / partnership agreements with major biopharmaceutical companies SJA Investment Banking: (i) Private Placements - Seed - Series A> via Reg CF, Reg A+, 506 b/c exemptions (ii) Alternative Public Offerings - Reverse Mergers (iii) Non-dilutive capital including NIH / SBIR and State-sponsored programs, CPRIT - Cancer Prevention Research Institute of Texas (iv) Mergers and Acquisitions (M&A) Securities are offered through Finalis Securities LLC Member FINRA / SIPC. S. Jordan Associates is not a registered broker-dealer, and Finalis Securities LLC and [Insert DBA Name] are separate, unaffiliated entities.
Chicago, Illinois, United States
Biotechnology Research
Family Office
—
No verticals classified
Investment Banking, Business Development, Crowdfunding, Strategic Advisory, Immune-Oncology, Gene Therapy
—
—
1
2007
Triage: advisor_broker — Investment banking advisory for life sciences fundraising and M&A
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.